Mylan Overcomes Biogen Bid For Tecfidera Injunction

Generics Firm Is Facing Appeal Over 2028-Expiring Patent Win

 
• By Dean Rudge
  
MylanOffice
Mylan may introduce generic Tecfidera at-risk before the year end • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin